Celebrating 40 years of care • Since 1986

Celebrating 40 years of care • Since 1986

When medicines can affect hearing: understand the risk

House of Hearing

Updated on

Illustration of pharmacist writing a medical prescription

A medicine can be important for treating a serious condition and still require monitoring for side effects. Some drugs have the potential to affect the inner ear’s hearing or balance function, a risk described as ototoxicity. The word describes a possibility associated with certain treatments, not a prediction that every person taking them will lose hearing.

Risk depends on the specific drug and the individual treatment situation. Reading a long side-effect list online cannot tell you how that risk compares with the benefits of your prescription. Your prescriber and pharmacist are the right people to interpret it for you.

Which treatments are relevant?

Certain antibiotics, including aminoglycosides, and some cancer treatments such as cisplatin are recognized examples. Other medicines can be associated with tinnitus, sometimes in relation to dose. These categories are not interchangeable, and neither a medication name nor a symptom alone confirms damage.

Do not stop, skip or reduce prescribed treatment because of an article or a new ringing sound. Contact the prescribing team promptly so they can decide how to evaluate the concern while protecting the reason the medicine was prescribed.

Watch for changes, not just complete loss of sound

Report newly muffled hearing, trouble understanding conversation, ringing or a new balance difficulty. Explain when it began, whether it affects one or both ears and whether the change is constant or intermittent. Include any recent loud-noise exposure or illness.

A sudden drop in hearing requires immediate medical attention. It should not be left until a routine follow-up or automatically attributed to a medication. There can be other causes, and prompt assessment matters.

Ask about monitoring before treatment when possible

For medicines with a known ear-related risk, ask whether a baseline hearing evaluation and follow-up monitoring are appropriate. A baseline gives the care team something to compare with later results. The timing and type of testing should match the treatment and your circumstances.

An audiologist can help identify changes and communicate findings to the medical team. The prescriber then weighs treatment decisions. Monitoring does not guarantee that a problem can be prevented, but it provides information that symptoms alone may not capture.

Make your information easy to share

Keep one current list of prescriptions, nonprescription medicines and supplements. Include dose changes and start dates if you know them. Take the list to a hearing assessment, and tell the hearing team which clinician is coordinating your treatment.

Before leaving an appointment, clarify whom to contact if symptoms appear and how urgently. Ask whether follow-up is needed after the course has finished. Those simple arrangements reduce the chance that each provider assumes someone else is checking.

If hearing changes remain, discuss support for communication and hearing-aid options where appropriate. The aim is to keep medical treatment and hearing care connected, without asking you to make medication decisions on your own. Contact us for help arranging the hearing side of that conversation.

Further reading: NIDCD: Ototoxic drugs; NIDCD: Cisplatin and hearing research; ASHA: Audiology and ototoxic medication monitoring; NIDCD: Sudden deafness.

Let’s find your next step.

Talk with our team about your hearing and the care that’s right for you.